The Educated Patient Podcast: Gout Without the Guesswork

On the latest episode of The Educated Patient Podcast, host Mike DeMarco spoke with Brian LaMoreaux, M.D., a practicing rheumatologist and executive medical director at Amgen, about a persistent misconception: that gout is a disease caused primarily by overeating or drinking too much. LaMoreaux explained that gout is fundamentally a kidney-based metabolic disease that develops when the kidneys fail to adequately remove uric acid from the body. As uric acid builds up, it can form monosodium urate crystals, typically in cooler areas of the body like the feet. When the immune system reacts to those crystals, the result is a gout flare, among the most painful experiences a person can have.

LaMoreaux said genetics accounts for roughly 41% of a person’s gout risk, compared with just 9% attributable to diet alone, with the remaining 50% reflecting an interaction between the two factors. He emphasized that even a near-perfect diet wouldn't prevent gout in someone genetically predisposed to it, since genetic background and kidney function play the dominant role.

Why Diet Advice Dominates the Conversation Anyway

Despite the science, LaMoreaux told DeMarco that diet-focused advice continues to dominate how gout is discussed online and even among some clinicians, noting that internet search results on gout care are disproportionately focused on food and drink despite thin scientific backing. He traced part of the misconception to historical stereotypes linking gout to wealth and indulgence, along with a broader human tendency to focus on controllable factors rather than genetics and kidney function, which are largely outside a person's control.

He was careful to distinguish diet’s minimal role in causing gout from its lack of a meaningful role in treatment. Alcohol operates similarly, LaMoreaux said: Heavier consumption can modestly raise uric acid levels, but this represents a small population-level effect rather than a meaningful treatment lever for most patients.

Treating Gout Requires Medication, Not Willpower

LaMoreaux explained that the only definitive way to resolve gout is to lower uric acid levels with medication, targeting a threshold of 6.8 to 7 milligrams per deciliter, the point at which crystals begin forming. Visible bumps under the skin, known as tophi, represent only a fraction of the total crystal burden in the body, he said, meaning each visible bump typically signals a far larger amount of crystal buildup beneath the surface.

Lowering uric acid can itself trigger flares as tophi begin dissolving, which is why patients often start an anti-inflammatory medication alongside uric acid-lowering treatment. LaMoreaux emphasized that lifestyle factors like hydration and circulation remain worth pursuing for general health, but they shouldn't be mistaken for gout treatment. He also noted that dehydration and physical activity, not diet, are actually more common flare triggers for most patients, a detail he said is often overlooked even by clinicians who default to asking patients what they ate before a flare.

The Hidden Toll of Living With Gout

Beyond the physical pain, LaMoreaux described a less visible consequence of chronic gout to DeMarco: isolation. Patients who experience frequent flares sometimes begin avoiding travel and social events out of fear of triggering one, leading many to describe feeling isolated by their condition even when they aren't actively experiencing a flare. LaMoreaux said this emotional toll, the loss of agency and the retreat from meaningful activities, is one of the most difficult aspects of the disease to witness as a clinician.

He pointed to the emergence of "clinical remission" as a treatment goal in gout care, defined by low uric acid levels, resolved tophi, and, most importantly for patients, the absence of flares. LaMoreaux noted that many patients live with five or more flares a year and simply accept it as their reality, when in fact, far better outcomes are achievable with the right treatment approach.

A Message for Patients

LaMoreaux encouraged patients to track their flares and share that information openly with their clinicians, since frequency data can meaningfully shape treatment decisions. He also stressed the importance of transparency in the patient-provider relationship, particularly around side effects or unexpected flares, noting that honest reporting allows clinicians to adjust treatment rather than assume a therapy has failed.

His closing message, delivered to DeMarco and the podcast's listeners: Gout is not a patient's fault and is highly treatable with the right clinician and medication. No one, he said, has to let gout control their life.